Intermedia Named a Leader in the Aragon Research Globe™ for the Intelligent Contact Center for SMB, 2025
Bringing enterprise-grade AI to SMBs, Intermedia is redefining what a modern contact center can do for businesses of all sizes—helping...
Month: March 2025
Ultromics Introduces AI-Powered Probability Scoring on EchoGo® Heart Failure for Enhanced HFpEF Diagnosis
OXFORD, England, March 28, 2025 /PRNewswire/ -- Ultromics, a pioneer in AI-driven cardiology solutions, has unveiled the latest enhancement to EchoGo® Heart...
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025
RADNOR, Pa., March 28, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services...
Dominari Holdings Reports Preliminary FY 2024 Financial Results
2024 Revenue Surges to Approximately $19 Million as Company Executes Growth and Expansion Strategy NEW YORK, March 28, 2025 /PRNewswire/...
SprintRay Inc. Announces API Integration with Align Technology’s iTero™ Intraoral Scanners to Further Ease Adoption into Chairside Digital Dentistry
LOS ANGELES, March 28, 2025 /PRNewswire/ -- SprintRay, a leader in dental 3D printing, announces a new application programming interface...
Growth Executive, Andrew Candreva, Joins Tantus Tech as Director of Strategy
ARLINGTON, Va., March 28, 2025 /PRNewswire/ -- Tantus Technologies, Inc. (Tantus), a leader in the federal IT consulting, is excited to...
Norton Orthopedic Institute surgeon performs new robotic-assisted shoulder replacement
Justin M. Givens, M.D., is among first five surgeons in U.S. to perform the surgery Norton Orthopedic Institute surgeon performs...
Transforming Wellness: Abundant Health Introduces RENEW Protocols for Lasting Relief
Davenport, Iowa, March 28, 2025 (GLOBE NEWSWIRE) -- Abundant Health Physical Medicine, a leading integrative wellness clinic in the Midwest,...
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage...
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinomaWALTHAM, Mass., March 28,...
Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data
Silexion’s new expanded dual-route strategy will integrate intratumoral and systemic administration to target both primary tumors and metastases, supported by...
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”),...
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
Call Scheduled for Monday, March 31, 2025 at 5:00 pm ETLITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics,...
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
BETHESDA, Md., March 28, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Beyond Medical Technologies Provides Business Strategy and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF)...
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative...
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology...
Aptose Reports Year End 2024 Results and Corporate Highlights
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third...
Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered...
Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
Regional Medical Leaders Embrace Daxor’s ezBVA Lab Service Oak Ridge, TN, March 28, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...